Live Q&A on the Healthcare and the Supreme Court with Lawrence Gostin, JD.

Tomorrow, Friday 2pm ET on Instagram Live.

Recent Supreme Court rulings are poised to significantly affect healthcare. In Loper Bright Enterprises v. Raimondo, the court overturned the Chevron doctrine, ending decades of deference to experts from federal agencies like the FDA and CMS. This shift could delay regulatory decisions on drug approvals, Medicare pricing, and nursing home oversight, and possibly overturn long-established federal rules.

In Moyle v. United States and Idaho v. United States, the court ruled that Idaho hospitals must continue providing emergency abortions under EMTALA if the mother's life is at risk, but it stopped short of broader rulings on abortion rights. Similarly, in FDA v. the Alliance for Hippocratic Medicine, the court preserved access to the abortion pill mifepristone (Mifeprex), but did so by sidestepping the issue. (The court decided that the doctors who brought the case didn't actually have the right to do so because they lacked "standing.") Legal experts have warned that these decisions were not true wins for reproductive rights; rather, they were short-term punts on technical grounds.

Join us for an upcoming Instagram Live where I will discuss the evolving legal landscape shaping healthcare access with an expert on healthcare law, Professor Lawrence O. Gostin, J.D.

Gostin serves as distinguished university professor at Georgetown University, co-faculty director at the O'Neill Institute, and director of the World Health Organization Collaborating Center on National & Global Health Law.

How do I join? Follow @medpage on Instagram! (We’ll post the video for those who can’t watch live.)

When is the event? Tune in Friday, September 27 at 2 pm ET.

Can I submit questions? Yes, we encourage questions! Submit your questions prior to the event by commenting below.